Navigation Links
Cardiac Science to Present at the Eighth Annual Invest Northwest Conference
Date:3/11/2009

BOTHELL, Wash., March 11 /PRNewswire-FirstCall/ -- Cardiac Science (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, today announced that it will present at the Washington Biotechnology and Biomedical Association (WBBA) 2009 Invest Northwest CEO and Investor Forum at the Bell Harbor International Conference Center in Seattle. Michael Matysik, senior vice president and chief financial officer, will review the Company's business strategy and recent financial results, during the Company's presentation on Wednesday, March 18 at 9:40 a.m. local time.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

Attendance at the conference is by invitation only. Cardiac Science will offer a live webcast of its presentation, which may be accessed at the Company's website at www.cardiacscience.com. An archived replay of the presentation will also be available following the live presentation and can be accessed at www.cardiacscience.com for 90 days.

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.


    For more information,

    Company Contact:                 Investor Contact:    Media Contact:
    Mike Matysik                     Doug Sherk           Christopher Gale
    Cardiac Science Corporation      Jenifer Kirtland     EVC Group Inc.
    Senior Vice President and CFO    EVC Group Inc.       646.201.5431
    425.402.2009                     415.896.6820         203.570.4681
                                                          cgale@evcgroup.com

CSCX-F


'/>"/>
SOURCE Cardiac Science
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Antidepressant Use Tied to Cardiac Death in Women
2. The Larry King Cardiac Foundation Brings its Annual Gala to Homes Across the Nation
3. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center First in Nation to Use NaviStar(R) RMT ThermoCool(R) Catheter Since Technology Received FDA Approval
4. Cardiac Science Schedules Fourth Quarter Earnings Release and Announces Conference Call
5. Landmark Trial Provides Vital Information for Cardiac Disease Treatment
6. Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference
7. Sudden Cardiac Death Rare in Young Athletes
8. Global Economic Meltdown - Is the European Cardiac Rhythm Management Market Spared?
9. TV News Coverage Reports on InnerCools CoolBlue System Treatment of Cardiac Shock Patient Following Childbirth at Rush Hospital, Chicago
10. Worlds First Cardiac Adult Stem Cell Trial to Take Place in Louisville
11. iCardiac's Highly Automated QT(sm) Technology Now Validated in Over 10 Clinical QT Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... July 26, 2017 , ... An inventor from Salisbury, N.C., knows the difficulties ... an effective and dignified way to keep leeches in place during therapy," she said. ... invention provides an effective way to keep a leech in place on the skin ...
(Date:7/26/2017)... ... July 26, 2017 , ... Written By: Ashley D. Beall, ... in drug therapy for patients living with relapsing and primary multiple sclerosis that ... cell targeted therapy that has been proven to significantly reduce signs of disease ...
(Date:7/26/2017)... ... July 26, 2017 , ... Evergreen Healthcare Partners is ... continued efforts to provide innovative offerings to their healthcare partners. These solutions will ... dynamic, high-performing teams to address healthcare IT’s biggest challenges. , “Adding Talent Management ...
(Date:7/26/2017)... ... , ... It may be hard to imagine that the basic necessities that ... world. Diseases that many developed countries consider rare or eradicated, like measles, are still ... , On an upcoming segment of "Success Files", actor Rob Lowe will introduce a ...
(Date:7/26/2017)... ... July 26, 2017 , ... The ... Process Validation and Process Validation Statistics Conferences in Bethesda, Maryland, 12 – ... challenges faced by process validation professionals and statisticians today. , “These conferences ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)...  Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... 2017 operating results on Monday, August 7, 2017 after ... 5:00 p.m. ET. ... broadcast of the conference call by dialing 877-201-0168 or ... approximately 15 minutes prior to the call. A live ...
(Date:7/21/2017)... and RESEARCH TRIANGLE PARK, N.C. ... Corporation (NASDAQ: UTHR ) announced today that ... before the market opens on Thursday, July 27, 2017. ... host a teleconference on Thursday, July 27, 2017, at ... dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A rebroadcast ...
(Date:7/21/2017)... , July 21, 2017 Did you know that ... in 2016? Or that combined spending on brand medicines, generics and ... spending, with brands accounting for just half of this (7 percent)? ... two thirds of the world,s venture capital investments in high-growth biopharmaceutical ... ...
Breaking Medicine Technology: